Moberg may seek new Emtrix partners in Europe

10 November 2015 - Deborah Wilkes

Archived

Moberg Pharma is evaluating options for launching its Emtrix OTC nail treatment in the UK, Poland and a number of other European Union countries. The Swedish company has also entered into a development agreement with Colep for MOB-015, a novel topical terbinafine formulation for treating nail fungus.

Click tags below for more information on topics:

Moberg

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: